This announcement is a separate document:
泰凌醫藥(新)：終止有關商業化權利許可的非常重大收購事項及變更配售事項所得款項用途
NT PHARMA-NEW: TERMINATION OF THE VERY SUBSTANTIAL ACQUISITION IN RELATION TO THE LICENSING OF COMMERCIALISATION RIGHT AND CHANGE IN USE OF PROCEEDS FROM THE PLACING
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.